Entity
  • Xegen

    Created in 2012
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    870
  • Activities

  • Entity types

  • Location

    15 Rue Dominique Piazza, 13420 Gémenos, France

    Gémenos

    France

  • Employees

    Scale: 2-10

    Estimated: 4

  • SIREN

    752957381
  • Engaged corporates

    0
    0 0
  • Added in Motherbase

    1 year, 5 months ago
Description
  • Value proposition

    Biostatistics & Bioinformatics company specialized in Next Generation Sequecing data analysis



    Xegen is a bioinformatics company specialized in Next Generation Sequencing (NGS) data analysis.
    We provide support for our customers or partners in their NGS data processing issues, through specific, automated, high added value bioinformatics analyzes.
    Xegen is developing Polypheme a bioinformatics suite dedicated to complex genes analysis (polymorphisms detection or allelic types).
    Polypheme analysis includes in particular HLA Typing, classic (HLA-A, -B, -C, DRB1, DQB1) and not classic genes (HLA-E, -F, -G, -H). Polypheme is also used to discover new alleles.


    Bioinformatics, Genomics, Typing, HLA, Diagnostics, NGS data analysis, and Personalized Medicine

  • XEGEN - CRO Specialized in bioinformatics / biostatitics

    Single point of contact for any type of NGS / RNA seq data analysis through customized solutions for genomics and transcriptomics

  • https://xegen.fr/
Corporate interactions BETA
Corporate TypeDate
No interactions
Similar entities
AxisEntities
No similarities
Last news
Xegen 2 weeks, 5 days ago

Once upon a time, 3 researchers decided to found Xegen with the ambition to extend biological knowledge thanks to the immense opportunities offered by the new sequencing technologies and innovant data analysis approaches

10 years have passed, the team has grown, our Polypheme software is deployed, our clients entrust us with more and more ambitious projects... and we are very proud of that.

This milestone gives us the opportunity to thank our customers, our partners, our supporters, and of course to thank our teams for the quality of their work and their abnegation.

Let's go for a new decade!

#birthday, #Xegen, #event

Xegen 2 months, 2 weeks ago

We are very proud to see 2 XEGEN papers on HLA-H gene analysis cited in this very interesting publication. Immunogenetics analysis remains a great challenge for the understanding of human health and we continue to be involved in these advances.
#Immunogenetics, #HLA, #Polypheme, #health
https://lnkd.in/eHiF2q-f

Xegen 2 months, 2 weeks ago

Meet @XEGEN at the European Immunogenetics and Histocompatibility congres (EFI 2022) Amsterdam May 17th-20th

Please book a meeting on
https://lnkd.in/e9a3_pV9

#HLA, #Polypheme, #Immunogenetics, #NGS

https://lnkd.in/e6zdQuNJ

Xegen 3 months, 3 weeks ago

We are proud to see that accurate HLA typing performed by Polypheme is again used as a reference in a very interesting study published in the famous journal Nature Genetics.
Our typing seems to become the reference in HLA typing for the 1000 genomes panel.
https://lnkd.in/ejNM6WVg
#HLA, #Polypheme, #NGS

Xegen 3 months, 3 weeks ago

Today we give a new feature to our software suite Polypheme with the integration with Singularity for HPC Servers:
- Easier installation
- Easier deployment
- Processes parallelization
Polypheme is our proprietary solution for genes analysis... that includes HLA class I and class II genes, with 99% precision.

https://lnkd.in/eNTX3iFG
#HLA, #Polypheme, #NGS

Social network dynamics